AARTIPHARM — Aarti Pharmalabs Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Aarti Pharmalabs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	R2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,603	990	1,007	559	89
Net Total Accounts Receivable
Net Total Receivables	3,882	4,524	5,893	6,530	6,952
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	10,281	11,558	13,456	13,182	13,973
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9,453	9,861	10,932	14,107	17,067
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	20,399	22,309	25,821	29,024	34,817
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5,807	5,916	6,944	6,531	9,376
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	6,534	6,724	8,251	9,125	13,571
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	13,865	15,585	17,570	19,899	21,246
Total Liabilities & Shareholders' Equity	20,399	22,309	25,821	29,024	34,817
Total Common Shares Outstanding